CRUK–AstraZeneca Antibody Alliance Laboratory

United Kingdom (UK)

1 June 2020 - 31 May 2021

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for CRUK–AstraZeneca Antibody Alliance Laboratory published between 1 June 2020 - 31 May 2021 which are tracked by the Nature Index.

Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Research collaboration: CRUK–AstraZeneca Antibody Alliance Laboratory is a research collaboration whose article contributions are accrued to its participating partner institutions.

Note: Articles may be assigned to more than one subject area.

Count Share
2 0.74

Outputs by subject (Share)

Subject Count Share
Life Sciences 2 0.74
Chemistry 1 0.67

Top articles by Altmetric score in current window

Extensive sequence and structural evolution of Arginase 2 inhibitory antibodies enabled by an unbiased approach to affinity maturation

Proceedings of the National Academy of Sciences of the United States of America

2020-07-02

1 June 2020 - 31 May 2021

International vs. domestic collaboration by Share

  • 85.98% Domestic
  • 14.02% International

Note: Hover over the graph to view the percentage of collaboration.

Top 10 domestic collaborators by Share (5 total)

  • CRUK–AstraZeneca Antibody Alliance Laboratory, United Kingdom (UK)
  • Domestic institution
  1. AstraZeneca plc, United Kingdom (UK) (1.25)
    0.74
    0.51
  2. Cancer Research UK (CRUK), United Kingdom (UK) (1.11)
    0.74
    0.37
  3. University of Leicester, United Kingdom (UK) (0.81)
    0.67
    0.14
  4. University of Oxford, United Kingdom (UK) (0.71)
    0.67
    0.05
  5. Wellcome Sanger Institute, United Kingdom (UK) (0.50)
    0.07
    0.43

Top 10 international collaborators by Share (3 total)

  • CRUK–AstraZeneca Antibody Alliance Laboratory, United Kingdom (UK)
  • Foreign institution
  1. Cancer Research Malaysia (CRM), Malaysia (0.46)
    0.07
    0.39
  2. H. Lee Moffitt Cancer Center & Research Institute, United States of America (USA) (0.14)
    0.07
    0.07
  3. University of Malaya (UM), Malaysia (0.11)
    0.07
    0.04

Note: Collaboration is determined by the fractional count (Share), which is listed in parentheses.

Participating institutions

CRUK–AstraZeneca Antibody Alliance Laboratory is a research collaboration whose article contributions are accrued to its participating partner institutions below.

Return to institution outputs